The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

truenorthrx.com

Founded Year

2013

Stage

Acquired | Acquired

Total Raised

$142M

Valuation

$0000 

About True North Therapeutics

True North Therapeutics is a clinical stage biopharmaceutical company focusing on the discovery, development and commercialization of first-in-class product candidates for complement-mediated diseases. The company's lead product candidate, TNT009, is designed to selectively inhibit a target in the classical complement pathway. True North's antibody drug development is focused on the treatment of certain rare diseases mediated by the complement system.

True North Therapeutics Headquarter Location

951 Gateway Blvd

South San Francisco, California, 94080,

United States

650-872-4700

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing True North Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

True North Therapeutics is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

838 items

True North Therapeutics Patents

True North Therapeutics has filed 11 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/20/2016

10/29/2019

Monoclonal antibodies, Complement system, Immune system, Immunology, Acetylcholinesterase inhibitors

Grant

Application Date

12/20/2016

Grant Date

10/29/2019

Title

Related Topics

Monoclonal antibodies, Complement system, Immune system, Immunology, Acetylcholinesterase inhibitors

Status

Grant

Latest True North Therapeutics News

Abzenas partner True North Therapeutics subject of US$825m takeover

Mar 16, 2020

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored ND2A Group with offices at 677 Craig Rd, Suite 216, Creve Coeur, Missouri 63141 USA. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters here: Contact ND2A Group . All rights reserved. All other trademarks recognized. Copyright © 2020 ND2A Group. Site developed by Alacrify Ltd .

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.